Evidence map›Paper›PMID 29450209›Full record

ArticleOpen forum infectious diseases2018

Creation and Assessment of a Clinical Predictive Calculator and Mortality Associated With

Ryan Kronen, Kevin Hsueh, Charlotte Lin, William G Powderly, Andrej Spec

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Reply to Collis et al.Open forum infectious diseases · 2023
    Article
  6. Article
  7. A seven-year surveillance ofJournal of Taibah University Medical Sciences · 2021
    Article
  8. Article
  9. Interaction Between Dendritic Cells andFrontiers in cellular and infection microbiology · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ryan KronenWashington University School of Medicine, St Louis, Missouri.
Kevin HsuehDivision of Infectious Diseases, St Louis, Missouri.
Charlotte LinDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri.
William G PowderlyDivision of Infectious Diseases, St Louis, Missouri.
Andrej SpecDivision of Infectious Diseases, St Louis, Missouri.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
NCATS NIH HHS KL2 TR002346NCATS NIH HHS UL1 TR002345NCEZID CDC HHS U54 CK000609
6 · The paper itself

Abstract

background

methodsWe conducted a retrospective analysis of hospitalized patients with

resultsWe identified 1873 individual patients who developed

conclusionsSix patient comorbidities predicted the development of CK BSI with high accuracy. Although patients with CK BSI have higher crude mortality rates than patients with non-CK BSI, this difference is not significant when accounting for other patient characteristics.

Indexed as

Candida kruseicandidemiaclinical predictive modelmortalityrisk factors

Identifiers

PMID29450209
PMCPMC5808796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.